Is the 4MGS a Useful Outcome Measure Post-PPCI

Is the Four Metre Gait Speed a Useful Outcome Measure in Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02261324

Enrollment

560

Registered

2014-10-10

Start date

2013-12-31

Completion date

2021-01-31

Last updated

2021-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Percutaneous coronary intervention

Brief summary

This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future cardiovascular events and death.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Any patient hospitalised with an acute myocardial infarction who has undergone primary percutaneous coronary intervention * Capacity to consent * Able to walk * Age over 18 years

Exclusion criteria

* Significant co-morbidities that would limit exercise capacity or make exercise unsafe (e.g. neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation)

Design outcomes

Primary

Measure	Time frame
Mortality rate	1 year

Secondary

Measure	Time frame
All-cause mortality	5 years
Cardiovascular death	1 and 5 years
Occurrence of cardiovascular events	1 and 5 years
Need for repeat revascularisation	1 and 5 years
Health resource usage	1 and 5 years

Countries

United Kingdom

Outcome results